Russell Investments Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.71K | Sell |
|
|||||
|
2024
Q3 | $13.3K | Sell |
|
|||||
|
2024
Q2 | $54.9K | Buy |
|
|||||
|
2024
Q1 | $12.1K | Sell |
|
|||||
|
2023
Q4 | $73.9K | Sell |
|
|||||
|
2023
Q3 | $244K | Buy |
|
|||||
|
2023
Q2 | $11.9K | Sell |
|
|||||
|
2023
Q1 | $99.1K | Sell |
|
|||||
|
2022
Q4 | $301K | Buy |
|
|||||
|
2022
Q3 | $92K | Sell |
|
|||||
|
2022
Q2 | $283K | Sell |
|
|||||
|
2022
Q1 | $543K | Sell |
|
|||||
|
2021
Q4 | $664K | Sell |
|
|||||
|
2021
Q3 | $1.06M | Sell |
|
|||||
|
2021
Q2 | $1.82M | Sell |
|
|||||
|
2021
Q1 | $4.06M | Buy |
|
|||||
|
2020
Q4 | $3.96M | Sell |
|
|||||
|
2020
Q3 | $3.89M | Buy |
|
|||||
|
2020
Q2 | $4.29M | Buy |
|
|||||
|
2020
Q1 | $3.01M | Buy |
|
|||||
|
2019
Q4 | $3.4M | Sell |
|
|||||
|
2019
Q3 | $4M | Buy |
|
|||||
|
2019
Q2 | $2.22M | Buy |
|
|||||
|
2019
Q1 | $1.14M | Buy |
|
|||||
|
2018
Q4 | $576K | Buy |
|
|||||
|
2018
Q3 | $126K | Sell |
|
|||||
|
2018
Q2 | $441K | Buy |
|
|||||
|
2018
Q1 | $304K | Buy |
|
|||||
|
2017
Q4 | $48K | Sell |
|
|||||
|
2017
Q3 | $54K | Sell |
|
|||||
|
2017
Q2 | $3.63M | Buy |
|
|||||
|
2017
Q1 | $51K | Sell |
|
|||||
|
2016
Q4 | $1.94M | Buy |
|